Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Ubrogepant approval date?

See the DrugPatentWatch profile for Ubrogepant

When was ubrogepant first approved?

Ubrogepant (brand name Ubrelvy) received its first FDA approval on December 23, 2019. [1]

What approval date do people usually mean—FDA first approval or later label expansions?

Most searches for “ubrogepant approval date” refer to the first FDA approval date for Ubrelvy. That date is December 23, 2019. [1]

Where does the approval date come from (and can it differ by jurisdiction)?

Approval dates can differ by country and by whether you mean the first approval versus later regulatory actions. For the FDA (U.S.), the first approval date is December 23, 2019. [1]

Related context: what product was approved on that date?

The approval on December 23, 2019 was for Ubrelvy (ubrogepant), used for the acute treatment of migraine. [1]

Sources
[1] https://www.drugs.com/history/ubrogepant.html



Other Questions About Ubrogepant :

ubrogepant (ubrelvy) Ubrogepant cost? Us patent ubrogepant synthesis spiro? Wo2013138418 ubrogepant patent? Ubrogepant patent spirocyclic synthesis? Spiro acid 197 ubrogepant patent? Ubrogepant ubrelvy?